TREVENTIS

TREVENTIS™ utilizes a proprietary, patented discovery engine - Common Conformational Morphology (CCM) - to identify druggable active sites in misfolded protein targets... Treventis™ Corporation is dedicated to treating and preventing protein misfolding diseases, utilizing Common Conformational Morphology (CCM).

Also known as: Treventis Corporation

Primary location: Dover United States